Yongmei Cao

1.4k total citations · 1 hit paper
24 papers, 927 citations indexed

About

Yongmei Cao is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Yongmei Cao has authored 24 papers receiving a total of 927 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Cancer Research and 6 papers in Epidemiology. Recurrent topics in Yongmei Cao's work include Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (4 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Yongmei Cao is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (4 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Yongmei Cao collaborates with scholars based in China, United Kingdom and United States. Yongmei Cao's co-authors include Yingchuan Li, Ping Feng, Jiawei Shang, Wei-Feng Huang, Fang Wu, Qin Tan, Xiaoping Zhang, Jian Xiao, Haijun Zhang and Zhen Zeng and has published in prestigious journals such as Scientific Reports, Cell Death and Differentiation and Journal of Cellular Physiology.

In The Last Decade

Yongmei Cao

23 papers receiving 921 citations

Hit Papers

Inhibitor of apoptosis-stimulating protein of p53 inhibit... 2020 2026 2022 2024 2020 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yongmei Cao China 15 437 340 323 132 125 24 927
Yufeng Zhang China 15 359 0.8× 293 0.9× 260 0.8× 99 0.8× 121 1.0× 66 984
Cristina Mambet Romania 8 297 0.7× 145 0.4× 175 0.5× 92 0.7× 65 0.5× 26 882
Li Zuo China 19 340 0.8× 212 0.6× 184 0.6× 77 0.6× 62 0.5× 81 837
Mengyuan Dai China 19 401 0.9× 130 0.4× 179 0.6× 151 1.1× 53 0.4× 74 874
Hirofumi Hamano Japan 16 225 0.5× 156 0.5× 115 0.4× 92 0.7× 58 0.5× 74 845
Jing Lin China 18 313 0.7× 219 0.6× 149 0.5× 198 1.5× 162 1.3× 73 1.3k
Mengmeng Yang China 17 244 0.6× 110 0.3× 102 0.3× 111 0.8× 95 0.8× 59 803
Sisi Chen China 16 414 0.9× 83 0.2× 155 0.5× 101 0.8× 99 0.8× 44 1.0k
Junlin Lu China 14 325 0.7× 203 0.6× 164 0.5× 69 0.5× 74 0.6× 33 760
Laura Márquez‐Expósito Spain 15 400 0.9× 93 0.3× 77 0.2× 171 1.3× 91 0.7× 31 916

Countries citing papers authored by Yongmei Cao

Since Specialization
Citations

This map shows the geographic impact of Yongmei Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongmei Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongmei Cao more than expected).

Fields of papers citing papers by Yongmei Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongmei Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongmei Cao. The network helps show where Yongmei Cao may publish in the future.

Co-authorship network of co-authors of Yongmei Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Yongmei Cao. A scholar is included among the top collaborators of Yongmei Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongmei Cao. Yongmei Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cao, Yongmei, Yong Zhong, Jiawei Shang, et al.. (2025). FLRT3 Overexpression Attenuates Ischemia–Reperfusion Induced Vascular Hyperpermeability and Lung Injury Through RND3. Lung. 203(1). 39–39.
2.
Shang, Jiawei, et al.. (2023). HMGB1 mediates lipopolysaccharide-induced macrophage autophagy and pyroptosis. BMC Molecular and Cell Biology. 24(1). 2–2. 18 indexed citations
3.
Cui, Jin, Yongmei Cao, & Yingchuan Li. (2023). Bone Mesenchymal Stem Cells Origin Exosomes are Effective Against Sepsis-Induced Acute Kidney Injury in Rat Model. International Journal of Nanomedicine. Volume 18. 7745–7758. 20 indexed citations
5.
Wu, Fang, Wei-Feng Huang, Qin Tan, et al.. (2021). ZFP36L2 regulates myocardial ischemia/reperfusion injury and attenuates mitochondrial fusion and fission by LncRNA PVT1. Cell Death and Disease. 12(6). 614–614. 35 indexed citations
6.
Cao, Yongmei, Wei-Feng Huang, Fang Wu, et al.. (2021). ZFP36 protects lungs from intestinal I/R-induced injury and fibrosis through the CREBBP/p53/p21/Bax pathway. Cell Death and Disease. 12(7). 685–685. 26 indexed citations
7.
Feng, Ping, Yingchuan Li, Yongmei Cao, et al.. (2021). Metabolomics Analysis of the Development of Sepsis and Potential Biomarkers of Sepsis‐Induced Acute Kidney Injury. Oxidative Medicine and Cellular Longevity. 2021(1). 6628847–6628847. 21 indexed citations
8.
Luo, Dan, et al.. (2020). Equity and efficiency of maternal and child health resources allocation in Hunan Province, China. BMC Health Services Research. 20(1). 300–300. 38 indexed citations
9.
Li, Yingchuan, Yongmei Cao, Jian Xiao, et al.. (2020). Inhibitor of apoptosis-stimulating protein of p53 inhibits ferroptosis and alleviates intestinal ischemia/reperfusion-induced acute lung injury. Cell Death and Differentiation. 27(9). 2635–2650. 400 indexed citations breakdown →
10.
Feng, Ping, Yong Guo, Yongmei Cao, et al.. (2019). Metabolomics Analysis of the Renal Cortex in Rats With Acute Kidney Injury Induced by Sepsis. Frontiers in Molecular Biosciences. 6. 152–152. 32 indexed citations
11.
Cao, Yongmei, Yujing Liu, Jiawei Shang, et al.. (2019). Ang-(1-7) treatment attenuates lipopolysaccharide-induced early pulmonary fibrosis. Laboratory Investigation. 99(12). 1770–1783. 30 indexed citations
12.
Gao, Hongqiang, et al.. (2017). Upregulation of NM23-E2 accelerates the liver regeneration after 40% decreased-size liver transplantation in rats. Journal of Surgical Research. 219. 325–333. 2 indexed citations
13.
Cao, Yongmei, et al.. (2016). MicroRNAs: Novel regulatory molecules in acute lung injury/acute respiratory distress syndrome. Biomedical Reports. 4(5). 523–527. 39 indexed citations
14.
Li, Yingchuan, Zhen Zeng, Yongmei Cao, et al.. (2016). Angiotensin-converting enzyme 2 prevents lipopolysaccharide-induced rat acute lung injury via suppressing the ERK1/2 and NF-κB signaling pathways. Scientific Reports. 6(1). 27911–27911. 120 indexed citations
15.
Wang, Donghao, et al.. (2016). The corrective effect of norepinephrine on hypotension induced by dexmedetomidine for critical patients: a clinical study. International Journal of Clinical Pharmacology and Therapeutics. 54(12). 987–991. 2 indexed citations
16.
Cao, Yongmei, Zhen Jiang, Zhen Zeng, et al.. (2015). Bcl-2 silencing attenuates hypoxia-induced apoptosis resistance in pulmonary microvascular endothelial cells. APOPTOSIS. 21(1). 69–84. 16 indexed citations
17.
Zhang, Yan, Hongyang Li, Yongmei Cao, Mao-nian Zhang, & Shihui Wei. (2015). Sirtuin 1 regulates lipid metabolism associated with optic nerve regeneration. Molecular Medicine Reports. 12(5). 6962–6968. 14 indexed citations
18.
Cao, Yongmei, Yan Zhang, & Mingwei Zhao. (2014). Single-Walled Carbon Nanohorns Inhibit Proliferation of Conjunctival Melanoma Cell Lines CRMM-1 and Involved in Energy Metabolism. Journal of Nanoscience and Nanotechnology. 15(2). 1821–1830. 3 indexed citations
19.
Cao, Yongmei, Mengran Zhang, Rui Huang, et al.. (2013). Immunosuppression induced by apoptosis of mixed lymphocyte culture is associated with p53. Molecular Medicine Reports. 7(3). 805–810. 1 indexed citations
20.
Wu, Di, Hongqi Li, Guoan Xiang, et al.. (2013). Adiponectin and Its Receptors in Chronic Hepatitis B Patients With Steatosis in China. Hepatitis Monthly. 13(4). e6065–e6065. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026